mortality/aging
• no mice are recovered postnatally
|
• some mice die between E10.5 and E12.5
• however, long-term supplementation of maternal diet with retinaldehyde survive postnatally
|
embryo
N |
• supplementation of maternal diet with retinaldehyde rescues embryonic defects
|
• posterior to second arches
|
• compacted cervical/upper trunk region at E9-E9.5
• supplementation of maternal diet with retinoic acid partially rescues embryonic defects
|
• cervical mesoderm patterning is abnormal
|
• at E9-E9.5
|
• at E10.5
|
• forelimb buds are hypoplastic or almost undetectable
|
• embryos are sometimes necrotic at E10.5
|
cardiovascular system
• hearts exhibit no distinct left-right atria, misaligned putative ventricles, and poor myocardial trabeculation
|
• mice exhibit abnormal blood stasis suggesting cardiovascular failure
|
craniofacial
• truncated nasal process
|
• posterior to second arches
|
facial cleft
(
J:177362
)
• severe nasal/facial clefting at E12.5
|
limbs/digits/tail
• after long-term retinaldehyde treatment, mice exhibit distal limb defects with shortened digits and soft tissue syndactyly particularly evident for hindlimb digits
|
• forelimb buds are hypoplastic or almost undetectable
|
• in mice rescued by long-term retinaldehyde treatment particularly evident for hindlimb digits
|
syndactyly
(
J:177362
)
• in mice rescued by long-term retinaldehyde treatment particularly evident for hindlimb digits
|
vision/eye
small lens
(
J:177362
)
• despite developing intracranially, eyes are not visible at E12.5
|
hearing/vestibular/ear
• small, sometimes duplicated
|
digestive/alimentary system
• poor morphological differentiation
|
• poor morphological differentiation
|
growth/size/body
facial cleft
(
J:177362
)
• severe nasal/facial clefting at E12.5
|
• at E10.5
|
behavior/neurological
endocrine/exocrine glands
liver/biliary system
nervous system
renal/urinary system
respiratory system
absent lungs
(
J:177362
)